financetom
Business
financetom
/
Business
/
BRIEF-Acri Capital Acquisition Corporation Announces Confidential Submission Of Draft Registration Statement On Form S-4 And Extension Of The Deadline For An Initial Business Combination
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Acri Capital Acquisition Corporation Announces Confidential Submission Of Draft Registration Statement On Form S-4 And Extension Of The Deadline For An Initial Business Combination
Apr 10, 2024 3:13 PM

April 10 (Reuters) - Acri Capital Acquisition Corp ( ACAC )

:

* ACRI CAPITAL ACQUISITION CORPORATION ANNOUNCES

CONFIDENTIAL

SUBMISSION OF DRAFT REGISTRATION STATEMENT ON FORM S-4 AND

EXTENSION OF THE DEADLINE FOR AN INITIAL BUSINESS COMBINATION

* ACRI CAPITAL ACQUISITION CORP ( ACAC ) - EXTEND DATE BY WHICH

COMPANY

MUST COMPLETE ITS INITIAL BUSINESS COMBINATION FROM APRIL 14,

2024 TO MAY 14, 2024

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Reunion Gold Announces Acceptance of Terms of Scope for Environmental and Social Impact Assessment on Oko West Project
Reunion Gold Announces Acceptance of Terms of Scope for Environmental and Social Impact Assessment on Oko West Project
Mar 12, 2024
10:52 AM EDT, 03/12/2024 (MT Newswires) -- Reunion Gold Corporation ( RGDFF ) says the Environmental Protection Agency (EPA) of Guyana has finalized and approved the Terms of Scope (ToS) for the Environmental and Social Impact Assessment (ESIA) on the Oko West Project in Guyana's Region 7. The ToS is required for Reunion to move forward with work on the...
US FDA staff raises concerns on Geron's blood disorder drug
US FDA staff raises concerns on Geron's blood disorder drug
Mar 12, 2024
March 12 (Reuters) - The U.S. Food and Drug Administration's staff reviewers said on Tuesday they were unclear if Geron's ( GERN ) blood disorder drug provided a clear benefit to patients in a late-stage trial and raised multiple safety concerns with the treatment. Geron ( GERN ) is seeking approval of the injectable drug, called imetelstat, for treating transfusion-dependent...
Broadridge Financial Solutions Launches New SaaS Platform for Enhanced Derivatives Trading
Broadridge Financial Solutions Launches New SaaS Platform for Enhanced Derivatives Trading
Mar 12, 2024
10:52 AM EDT, 03/12/2024 (MT Newswires) -- Broadridge Financial Solutions ( BR ) said Tuesday it launched its global Futures and Options Software-as-a-Service platform to expand its derivatives trading capabilities. The new platform is expected to improve order and execution management capabilities for sell-side institutions, delivering new derivatives trading capabilities for global players in the Futures Commission Merchant community, the...
Newly Listed Obesity Player Fractyl Health Shares Encouraging Preclinical Data
Newly Listed Obesity Player Fractyl Health Shares Encouraging Preclinical Data
Mar 12, 2024
Tuesday, Fractyl Health Inc ( GUTS ) released new preclinical findings for the first clinical candidate in its Rejuva pancreatic gene therapy platform.  RJVA-001 is the company’s first GLP-1 gene therapy candidate to emerge from the platform, setting the stage for a potentially transformative approach to treating metabolic diseases, including obesity and T2D. Related Content: Weight-Loss Drug Gold Rush Gets Larger As New Player...
Copyright 2023-2026 - www.financetom.com All Rights Reserved